Morgan Stanley raises Amgen stock price target on obesity drug potential

Morgan Stanley raises Amgen stock price target on obesity drug potential  Investing.com Nigeria

Summary aggregated from Investing.com Nigeria's public RSS feed. The full reporting belongs to Investing.com Nigeria — please read it on their site.